newsfilter
← Latest News
PR Newswire·

Compugen Added to the NASDAQ Biotechnology Index

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has...